Delivery Order SPE2DB22D3019-SPE2DB25FK3MG

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $4.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, with a ceiling value of $1,880.52 and a completion date of May 16, 2025. The contract is not set aside and was awarded on May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,346.40 contract is for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product used to treat respiratory conditions. The award has an ultimate completion date of July 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a medication used for the treatment of respiratory conditions. The award has a ceiling value of $12,191.57 and a completion date of June 11, 2025. This delivery order is not associated with a set-aside program, indicating open...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a ceiling value of $1,989.44 and a completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 115-21 12GM, a respiratory medication. The $2,956.10 contract has an ultimate completion date of April 24, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a $9,940.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, with a period of performance through July 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,547.97 firm fixed price delivery order is for the supply of FLUTICASONE-SALMETEROL 115-21 12GM, a medication, with a completion date of June 12, 2025. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a $3,647.79 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a period of performance through June 16, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,571.64 firm fixed-price contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product, with a completion date of May 19, 2025. The contract is not set-aside and represents an award under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a federal Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,322.70, is for the supply of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product used in medical care. The contract has a Period of Performance through July 25, 2024 and is a Firm Fixed Price agreement. This award is part of a larger Indefinite...
  • SPE2DB22D3019
    Indefinite Delivery Contract
  • SPE2DB22D3019-SPE2DB25FK3MG
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,847.01, is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication. The award has an ultimate completion date of April 21, 2025.

This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. It allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

The contract has no set-aside designation, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp plays a critical role in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/18/25, 10:12 AM